FDA Issues Psychedelic Research Guidance for Industry
www.psychedelicweek.com
Covers clinical trials of psilocybin, MDMA, and LSD, including the role of therapy, abuse potential, adverse events, participant blinding, investigator qualifications, and theoretical cardiac risk
FDA Issues Psychedelic Research Guidance for Industry
FDA Issues Psychedelic Research Guidance for…
FDA Issues Psychedelic Research Guidance for Industry
Covers clinical trials of psilocybin, MDMA, and LSD, including the role of therapy, abuse potential, adverse events, participant blinding, investigator qualifications, and theoretical cardiac risk